VERTEX PHARMACEUTICALS INC / MA FY2025 benchmark
Not classified · Not classified. Only figures matched to an original company report are shown.
Sourced figures
- Revenue · VERTEX PHARMACEUTICALS INC / MA FY2025 — SEC XBRL company filing
- $12.00bnSource
Not classified · Not classified. Only figures matched to an original company report are shown.